; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (168) Iprodione and trifloxystrobin formulations Heading 9902.09.70 is amended— (A) by amending the article description to read as follows: Mixtures containing 3-(3,5-dichlorophenyl)-N-isopropyl-2,4-dioxo-1-imidazolidinecarboxamide (Iprodione) (CAS No. 36734–19–7) and methyl (2E)-(methoxyimino) [2-({[(E)-{1-[3-(trifluoromethyl) phenyl]ethylidene}amino]oxy}methyl)phenyl] acetate (Trifloxystrobin) (CAS No. 141517–21–7) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (169) Tetraconazole and azoxystrobin Heading 9902.09.71 is amended— (A) by amending the article description to read as follows: Mixtures of 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)-propyl]-1H-1,2,4-triazole (Tetraconazole) (CAS No. 112281–77–3), methyl (2E)-2-(2-{[6-(2-cyanophenoxy)-4-pyrimidinyl]oxy}phenyl)-3-methoxyacrylate (Azoxystrobin) (CAS No. 131860–33–8) and application adjuvants (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (170) Mixtures of at least 95 percent by weight allyl isothiocyanate and application adjuvants Heading 9902.09.75 is amended— (A) by amending the article description to read as follows: Mixtures of at least 95 percent by weight allyl isothiocyanate (3-isothiocyanato-1-propene) (CAS No. 57–06–7), and application adjuvants (provided for in subheading 3808.92.28) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (171) Polyoxin D zinc salt Heading 9902.09.79 is amended— (A) by amending the article description to read as follows: Formulations of zinc 1-{(2R,3R,4S,5R)-5-[(S)-{[(2S,3S,4S)-2-amino-5-carbamoyloxy)-3,4-dihydroxypentanoyl] amino}(carboxylato)methyl]-3,4-dihydroxytetrahydro-2-furanyl}-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate (Polyoxin D zinc salt) (CAS No. 146659–78–1) (provided for in subheading 3808.92.50)